Aster DM Quality Care to acquire 12% of United CIIGMA Hospital
What's the deal? Aster DM Quality CareDealroom has a profile for this one. Try Dealroom → will buy up to 12% additional equity in United CIIGMA HospitalDealroom has a profile for this one. Try Dealroom → for up to ₹40.93 crore in cash. Its board approved the move on August 5, 2026, after minority shareholders exercised put options. In the same meeting, it exited a separate underperforming hospital.
Why now? The purchase stems from put option rights held by certain minority shareholders under a shareholders' agreement dated June 10, 2022. The transaction is at arm's length, needs no further regulatory approval, and should close within one to two months.
What's the endgame? The deal deepens Aster's control over United CIIGMA Hospital, a healthcare company incorporated in 2011 and based in Chhatrapati Sambhajinagar. By buying out minority holders, it reduces potential dilution and governance friction while consolidating a larger revenue base.
By the numbers: United CIIGMA Hospital reported turnover of ₹153.64 crore for the year ended March 31, 2026. It has authorised share capital of ₹52 crore and paid-up capital of ₹51.36 crore.
The other half of the story: Aster is winding down its operations at Aster G. Madegowda Hospital in Maddur, ending an operations and management agreement first signed on April 1, 2023. The facility contributed just 0.15% of revenue last year and has run sustained losses since it opened.
The signal: The twin moves point to a familiar consolidation playbook — buy deeper into profitable assets, shed loss-making ones. With the Maddur exit costing little in revenue and the United CIIGMA Hospital stake securing a far larger base, Aster is tilting resources toward its stronger facilities.
Read more: ScanX
Image credit: ell brown
